Correlation Between Denali Therapeutics and Equillium
Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Denali Therapeutics and Equillium, you can compare the effects of market volatilities on Denali Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Equillium.
Diversification Opportunities for Denali Therapeutics and Equillium
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Denali and Equillium is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Equillium go up and down completely randomly.
Pair Corralation between Denali Therapeutics and Equillium
Given the investment horizon of 90 days Denali Therapeutics is expected to under-perform the Equillium. But the stock apears to be less risky and, when comparing its historical volatility, Denali Therapeutics is 1.53 times less risky than Equillium. The stock trades about -0.02 of its potential returns per unit of risk. The Equillium is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 201.00 in Equillium on January 25, 2024 and sell it today you would lose (22.00) from holding Equillium or give up 10.95% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Denali Therapeutics vs. Equillium
Performance |
| Timeline |
| Denali Therapeutics |
| Equillium |
Denali Therapeutics and Equillium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Denali Therapeutics and Equillium
The main advantage of trading using opposite Denali Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.| Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular TherapeuticsInc | Denali Therapeutics vs. Ascendis Pharma AS |
| Equillium vs. Lyra TherapeuticsInc | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |